2,056
|
16438 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
2440624
|
Diabetes mellitus, type II
Insulin resistance
|
11,717
|
116319 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
30404071
|
Diabetes mellitus, type II
Insulin resistance
|
11,748
|
116304 |
Renin
|
|
increases_quantity of
|
Angiotensin I
|
|
116310 |
AGT
|
|
increases_quantity of
|
Angiotensin I
|
via cleavage by renin
|
116361 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin II
|
via cleavage by ACE
|
116363 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
|
116364 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin (1-9)
|
via the catalytic activity of ACE2
|
116366 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
32333398
|
COVID-19
|
11,751
|
116385 |
MME
|
|
decreases_quantity of
|
Angiotensin I
|
|
116894 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin (1-7)
|
via catalytic action of MME (NEP)
|
117231 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
15283675
|
Endocrine
|
11,776
|
116540 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
|
116577 |
REN
|
|
increases_quantity of
|
Angiotensin I
|
|
116580 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
116584 |
MME
|
|
decreases_quantity of
|
Angiotensin I
|
|
116586 |
PREP
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
23463883
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
11,822
|
116794 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
116797 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin (1-9)
|
via the catalytic activity of ACE2
|
|
32336612
|
COVID-19
|
11,823
|
116859 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
with low activity as for angiotensin II
|
|
11815627
|
Metabolic
|
11,837
|
116863 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
|
116867 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin II
|
via the catalytic activity of ACE
|
116868 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin (1-9)
|
via the catalytic activity of ACE2
|
116869 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
10969042
|
Endocrine
|
11,844
|
116935 |
THOP1
|
|
decreases_quantity of
|
Angiotensin I
|
in hippocampus
|
116937 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin (1-7)
|
in hippocampus; via the catalytic action of THOP1
|
|
24041943
|
Neurological
|
12,020
|
117796 |
REN
|
|
increases_quantity of
|
Angiotensin I
|
in blood plasma
|
117798 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
|
117851 |
CTSD
|
|
increases_quantity of
|
Angiotensin I
|
|
117853 |
CTSG
|
|
increases_quantity of
|
Angiotensin I
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
12,027
|
117939 |
ACE
|
|
increases_quantity of
|
Angiotensin I
|
in blood serum
|
117940 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
in blood serum
|
|
22490446
|
Cardiovascular disease
|
12,028
|
117945 |
Angiotensin (1-12)
|
|
increases_quantity of
|
Angiotensin I
|
in atrium
|
|
22180785
|
Cardiovascular disease
|
12,029
|
117996 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
117997 |
CTSA
|
|
decreases_quantity of
|
Angiotensin I
|
|
117999 |
CPA3
|
|
decreases_quantity of
|
Angiotensin I
|
|
118007 |
PREP
|
|
decreases_quantity of
|
Angiotensin I
|
|
118009 |
THOP1
|
|
decreases_quantity of
|
Angiotensin I
|
|
118011 |
NLN
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
12,030
|
117988 |
CMA1
|
|
decreases_quantity of
|
Angiotensin I
|
in heart left ventricle
|
|
2266130
|
Cardiovascular disease
|
12,035
|
118078 |
ENPEP
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
12,056
|
118256 |
REN
|
|
increases_quantity of
|
Angiotensin I
|
in blood; via classical renin-angiotensin system
|
118257 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
in blood; via classical renin-angiotensin system
|
118345 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
19065996
|
Diabetes mellitus, type II
Insulin resistance
|
12,082
|
118661 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
32348783
|
Cardiovascular disease
COVID-19
|
12,193
|
119615 |
PREP
|
|
decreases_quantity of
|
Angiotensin I
|
in endothelial cells
|
|
1310484
|
Metabolic
|
12,194
|
119777 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
119779 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin (1-9)
|
via ACE2
|
|
32127770
|
Neurodegenerative disorder
|
14,059
|
132857 |
MME
|
|
decreases_quantity of
|
Angiotensin I
|
in kidney
|
|
32564694
|
Renal
|
14,176
|
133977 |
AGT
|
|
increases_quantity of
|
Angiotensin I
|
in kidney
|
142553 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin II
|
in kidney
|
142593 |
ACE
|
|
decreases_quantity of
|
Angiotensin I
|
in kidney
|
|
19065132
|
Nephropathy, diabetic
|
14,198
|
134054 |
CTSG
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
|
Cardiovascular disease
|
14,207
|
134096 |
Angiotensinogen
|
|
increases_quantity of
|
Angiotensin I
|
in brain; via renin
|
134121 |
Angiotensin I
|
|
increases_quantity of
|
Angiotensin II
|
in brain; via ACE
|
|
11295571
|
Cardiovascular disease
|
14,214
|
134201 |
REN
|
|
increases_quantity of
|
Angiotensin I
|
in kidney
|
|
21321306
|
Endocrine
Renal
|
14,225
|
134285 |
ATP6AP2
|
|
increases_quantity of
|
Angiotensin I
|
together with (pro)renin
|
134295 |
Renin
|
|
increases_quantity of
|
Angiotensin I
|
|
134296 |
Prorenin
|
|
increases_quantity of
|
Angiotensin I
|
if prorenin is bound to (P)RR
|
|
31164719
|
Renal
|
14,279
|
134714 |
COVID-19
|
|
decreases_quantity of
|
Angiotensin I
|
in plasma
|
|
33539316
|
COVID-19
|
14,302
|
134950 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
134959 |
MME
|
|
decreases_quantity of
|
Angiotensin I
|
|
|
32305401
|
Cardiovascular disease
COVID-19
|
14,449
|
136358 |
Renin
|
|
increases_quantity of
|
Angiotensin I
|
|
|
10585461
|
Endocrine
Renal
Nephropathy, diabetic
|
14,452
|
136405 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
in kidney
|
|
26995300
|
Renal
|